Seminars in Hematology
Volume 47, Supplement 1 , Pages S18-S20, April 2010

Status of Ongoing Collaborative Efforts

  • Julie M. Vose

      Affiliations

    • Corresponding Author InformationAddress correspondence to Julie M. Vose, MD, Division of Hematology/Oncology, 987680 Nebraska Medical Center, Omaha, NE 68198-7680

Division of Hematology/Oncology, University of Nebraska Medical Center, Omaha, NE

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 STATEMENT OF CONFLICT OF INTEREST: Dr. Vose discloses the following relationships: Contracted Research: GSK, Applied Molecular Evolution, Celgene, Allos, Astellas, Millennium, Genetech, Rigel, Bristol-Myers, Genzyme, Pharmacyclics, Novartis.

PII: S0037-1963(10)00017-X

doi:10.1053/j.seminhematol.2010.01.016

Seminars in Hematology
Volume 47, Supplement 1 , Pages S18-S20, April 2010

Article Tools